Cargando…
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer
Malnutrition is a frequent comorbidity in head and neck cancer patients and has been shown to impair immunotherapy response in other cancer types. The geriatric nutritional risk index (GNRI) assesses malnutrition using the patient’s ideal weight, actual weight, and serum albumin. The aim of this stu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961934/ https://www.ncbi.nlm.nih.gov/pubmed/36839241 http://dx.doi.org/10.3390/nu15040880 |
_version_ | 1784895878317735936 |
---|---|
author | Haas, Markus Lein, Alexander Fuereder, Thorsten Brkic, Faris F. Schnoell, Julia Liu, David T. Kadletz-Wanke, Lorenz Heiduschka, Gregor Jank, Bernhard J. |
author_facet | Haas, Markus Lein, Alexander Fuereder, Thorsten Brkic, Faris F. Schnoell, Julia Liu, David T. Kadletz-Wanke, Lorenz Heiduschka, Gregor Jank, Bernhard J. |
author_sort | Haas, Markus |
collection | PubMed |
description | Malnutrition is a frequent comorbidity in head and neck cancer patients and has been shown to impair immunotherapy response in other cancer types. The geriatric nutritional risk index (GNRI) assesses malnutrition using the patient’s ideal weight, actual weight, and serum albumin. The aim of this study was to evaluate the prognostic relevance of malnutrition as determined by the GNRI for the response to immunotherapy in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). A total of 162 patients with R/M HNSCC who received immune checkpoint inhibitors were included. The associations between the GNRI and progression-free survival (PFS), overall survival (OS), and the disease control rate (DCR) were computed. Univariable analysis showed worse PFS for GNRI ≤ 98 (p < 0.001), ECOG performance status (PS) ≥ 2 (p = 0.012), and enteral (p = 0.009) and parenteral (p = 0.015) nutritional supplementation, and worse OS for GNRI < 92 (p < 0.001), ECOG PS ≥ 2 (p < 0.001), and enteral (p = 0.008) and parenteral (p = 0.023) nutritional supplementation. In our multivariable model, GNRI ≤ 98 (p = 0.012) and ECOG PS ≥ 2 (p = 0.025) were independent prognostic factors for PFS. For OS, GNRI < 92 (p < 0.001) and ECOG PS ≥ 2 (p < 0.001) were independent prognostic factors. A GNRI ≤ 98 was significantly associated with a lower DCR compared to a GNRI > 98 (p = 0.001). In conclusion, our findings suggest that the GNRI may be an effective predictor for response to immunotherapy in R/M HNSCC. |
format | Online Article Text |
id | pubmed-9961934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99619342023-02-26 The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer Haas, Markus Lein, Alexander Fuereder, Thorsten Brkic, Faris F. Schnoell, Julia Liu, David T. Kadletz-Wanke, Lorenz Heiduschka, Gregor Jank, Bernhard J. Nutrients Article Malnutrition is a frequent comorbidity in head and neck cancer patients and has been shown to impair immunotherapy response in other cancer types. The geriatric nutritional risk index (GNRI) assesses malnutrition using the patient’s ideal weight, actual weight, and serum albumin. The aim of this study was to evaluate the prognostic relevance of malnutrition as determined by the GNRI for the response to immunotherapy in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). A total of 162 patients with R/M HNSCC who received immune checkpoint inhibitors were included. The associations between the GNRI and progression-free survival (PFS), overall survival (OS), and the disease control rate (DCR) were computed. Univariable analysis showed worse PFS for GNRI ≤ 98 (p < 0.001), ECOG performance status (PS) ≥ 2 (p = 0.012), and enteral (p = 0.009) and parenteral (p = 0.015) nutritional supplementation, and worse OS for GNRI < 92 (p < 0.001), ECOG PS ≥ 2 (p < 0.001), and enteral (p = 0.008) and parenteral (p = 0.023) nutritional supplementation. In our multivariable model, GNRI ≤ 98 (p = 0.012) and ECOG PS ≥ 2 (p = 0.025) were independent prognostic factors for PFS. For OS, GNRI < 92 (p < 0.001) and ECOG PS ≥ 2 (p < 0.001) were independent prognostic factors. A GNRI ≤ 98 was significantly associated with a lower DCR compared to a GNRI > 98 (p = 0.001). In conclusion, our findings suggest that the GNRI may be an effective predictor for response to immunotherapy in R/M HNSCC. MDPI 2023-02-09 /pmc/articles/PMC9961934/ /pubmed/36839241 http://dx.doi.org/10.3390/nu15040880 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Haas, Markus Lein, Alexander Fuereder, Thorsten Brkic, Faris F. Schnoell, Julia Liu, David T. Kadletz-Wanke, Lorenz Heiduschka, Gregor Jank, Bernhard J. The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer |
title | The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer |
title_full | The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer |
title_fullStr | The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer |
title_full_unstemmed | The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer |
title_short | The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer |
title_sort | geriatric nutritional risk index (gnri) as a prognostic biomarker for immune checkpoint inhibitor response in recurrent and/or metastatic head and neck cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961934/ https://www.ncbi.nlm.nih.gov/pubmed/36839241 http://dx.doi.org/10.3390/nu15040880 |
work_keys_str_mv | AT haasmarkus thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT leinalexander thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT fuerederthorsten thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT brkicfarisf thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT schnoelljulia thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT liudavidt thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT kadletzwankelorenz thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT heiduschkagregor thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT jankbernhardj thegeriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT haasmarkus geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT leinalexander geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT fuerederthorsten geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT brkicfarisf geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT schnoelljulia geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT liudavidt geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT kadletzwankelorenz geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT heiduschkagregor geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer AT jankbernhardj geriatricnutritionalriskindexgnriasaprognosticbiomarkerforimmunecheckpointinhibitorresponseinrecurrentandormetastaticheadandneckcancer |